Impact of health monitoring of clenbuterol in Guerrero, Mexico: Results from 2011 to 2015
DOI:
https://doi.org/10.22319/rmcp.v10i1.4350Keywords:
Clenbuterol, Food poisoning, Health surveillance.Abstract
The use of clenbuterol in livestock production entails risks to human health that must be characterized and managed by the agricultural and health authorities. This work evaluated the results of the health surveillance program of this compound in bovine meat products that are commercialized in Guerrero, Mexico. A retrospective analysis of the evolution of the illegal use of clenbuterol and of the record of food poisoning with this chemical was carried out for the 2011–2015 period. The rate of positive samples decreased gradually to be 6.8 % in 2015 and, in general, was lower in comparison with the immediate antecedents; however, it was always higher than the average rates obtained in the rest of the country (Guerrero= 9.5 %, National= 5.8 %). The health jurisdictions with the greatest presence of the drug were Tierra Caliente and the North, with 12.1 and 16.8 %, respectively, as well as in locations with a large population like Acapulco (9.6 %). Few cases of human poisoning were reported in the first three years of the period (3 in 2011, 5 in 2012, and 4 in 2013) and none in the two subsequent years; however, there is an under-registration issue, which may be due to different individual, regional and institutional factors that are discussed further below. The progress observed in this program should be maintained by strengthening health surveillance with the aim to eradicate this illegal activity in the short term.
Downloads
References
Sillence MN, Mathews ML, Badran TW, Pegg GG. Effects of clenbuterol on growth in underfed cattle. Austr J Agric Res 2000;51:401-406.
Sakai N, Sakai M, Mohamad-Haron DE, Yoneda M, Ali-Mohd M. Beta-agonist residues in cattle, chicken and swine livers at the wet market and the environmental impacts of wastewater from livestock farms in Selangor State, Malaysia. Chemosphere 2016;165:183-190.
Kearns CF, McKeever KH, Malinowski K, Struck MB, Abe T. Chronic administration of therapeutic levels of clenbuterol acts as a repartitioning agent. J Appl Physiol 2001;91:2064-2070.
Peters AR. b-agonists as repartitioning agents: a review. Vet Rec 1989;124:417-420.
Mitchell GA, Dunnavan G. Illegal use of β-adrenergic agonists in the United States. J Anim Sci 1998;76:208-211.
Brett J, Dawson AH, Brown JA. Clenbuterol toxicity: a NSW poisons information centre experience. Med J Aust 2014;200(4):219-221.
Hoey AJ, Matthews ML, Badran TW, Peg GG, Sillence MN. Cardiovascular effects of clenbuterol are β2-adrenoreceptor-mediated in steers. J Anim Sci 1995;73:1754-1765.
Brambilla G, Cenci T, Franconi F, Galarini R, Macri A, Rondoni F, Strozzi M, Loizzo A. Clinical and pharmacological profile in a clenbuterol epidemic poisoning of contaminated beef meat in Italy. Toxicol Lett 2000;114(1-3):47-53.
FAO/WHO Expert Committee on Food Additives. Residues of some veterinary drugs in animals and foods. Monographs prepared by the Fourth Meeting of the Joint FAO/WHO Expert Committee on Food Additives. Geneva. 1992.
Hoffman RJ, Hoffman RS, Freyberg CL, Poppenga RH, Nelson LS. Clenbuterol ingestion causing prolonged tachycardia, hypokalemia, and hypophosphatemia with confirmation by quantitative levels. Clin Toxicol 2001;39(4):339-344.
Diario Oficial de la Federación. NOM-194-SSA1-2004, Productos y Servicios. Especificaciones sanitarias en los establecimientos dedicados al sacrificio y faenado de animales para abasto, almacenamiento, transporte y expendio. Especificaciones sanitarias de productos. http://www.salud.gob. mx/unidades/cdi/nom/194ssa104.html. Consultado 25 Mar, 2016.
R-Biopharm AG. Enzyme immunoassay for the quantitative analysis of Clenbuterol and other β-agonists. http://www.r-biopharm.com/products/food-feed-analysis/residues/hormones-and-anabolics/clenbuterol/item/ridascreen -clenbuterol-fast. Accessed Apr 27, 2015.
Instituto Mexicano de Normalización y Certificación. NMX-EC-17025-IMNC-2006 Requisitos generales para la competencia de los laboratorios de ensayo y de calibración. México. 2006.
Comisión Federal para la Protección contra Riesgos Sanitarios. Comisión de Operación Sanitaria. Instrucción de trabajo para la vigilancia sanitaria del clembuterol en productos cárnicos. México, DF. Secretaría de Salud. 2008.
Chávez LA, Diaz JA, Pérez B, Alarcón MA. Tendencia de 2005 a 2010 de los niveles de clembuterol en muestras de bovinos en Guerrero, México. Rev Mex Cienc Pecu 2012;3(4):449-458.
Smith DJ, Paulson GD. Distribution, elimination, and residues of [14C] clenbuterol HCl in Holstein calves. J Anim Sci 1997;75(2):454-461.
Harkins JD, Woods WE, Lehner AF, Fisher M, Tobin T. Clenbuterol in the horse: urinary concentrations determined by ELISA and GC/MS after clinical doses. J Vet Pharma Therapeutics 2001;24:7-14.
Dave M, Sauer MJ, Fallon RJ. Clenbuterol plasma pharmacokinetics in cattle. Analyst 1998;123:2697-2699.
Yang YG, Song LX, Jiang N, Xu XT, Di XH, Zhang M. Pharmacokinetics of ambroxol and clenbuterol tablets in healthy Chinese volunteers. Int J Clin Exp Med 2015;8(10):18744-18750.
Li L, Tang C, Zhao Q, Zhang K. The potential of various living tissues for monitoring clenbuterol abuse in food-producing Chinese Simmental beef cattle. J Anal Toxicol 2016;40(1):72-77.
Wu ML, Deng JF, Chen Y, Chu WL, Hung DZ, Yang CC. Late diagnosis of an outbreak of leanness-enhancing agent-related food poisoning. Am J Emerg Med 2013;31(10):1501-1503.
Downloads
Published
How to Cite
-
Abstract1393
-
PDF (Español)404
-
PDF165
-
Texto Completo (Español)328
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
